Sign in
4

Changes in Ownership

Xilio Therapeutics, Inc. Filed Acc 0001062993-24-020910

10% owner bought 1,759,978 shares at $1.04 ($1,830,377)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
GILEAD SCIENCES, INC. 10% owner 2024-12-18 Purchase +1,759,978 $1.04 $1,830,377 9,105,451 D
Derivatives
GILEAD SCIENCES, INC. 10% owner 2024-12-18 Purchase · Prefunded Warrants (right to buy) +6,092,816 $1.04 $6,335,919 9,975,266 D
Open-market purchases · 1,759,978 sh · avg $1.04 · $1,830,377
Loading xslF345X05/form4.xml…